Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

Souvik Mitra; Courtney E. Gardner; Abigale MacLellan; Tim Disher; Danielle M. Styranko; Stefan Kuhle; Bradley C. Johnston; Jon Dorling

doi:10.1002/14651858.CD013846

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

Souvik Mitra, Courtney E. Gardner, Abigale MacLellan, Tim Disher, Danielle M. Styranko, Stefan Kuhle, Bradley C. Johnston, Jon Dorling

Medicine

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the comparative effectiveness and safety of prophylactic cyclo-oxygenase inhibitor (COX-I) drugs (indomethacin, ibuprofen, or acetaminophen) and 'no COX-I prophylaxis' in preterm infants, using a Bayesian network meta-analysis.

Original language	English
Article number	CD013846
Journal	Cochrane Database of Systematic Reviews
Volume	2021
Issue number	1
DOIs	https://doi.org/10.1002/14651858.CD013846
Publication status	Published - Jan 16 2021

Bibliographical note

Funding Information:
We would like to thank Cochrane Neonatal: Colleen Ovelman (Managing Editor), Jane Cracknell (Assistant Managing Editor), Roger Soll (Co-coordinating editor), and Bill McGuire (Co-coordinating Editor), who provided editorial and administrative support. We would also like to thank Robin Parker (WK Kellogg Health Sciences Library, Dalhousie University), as the creator of these searches, and Leah Boulos (Evidence Synthesis Co-ordinator, Maritime SPOR SUPPORT Unit), for her peer review of the MEDLINE search strategy. Menelaos Konstantinidis, Kerry Dwan (Cochrane Methods Support Unit) and Prakeshkumar Shah (Cochrane Neonatal Senior Editor) peer-reviewed and offered feedback for this protocol. The methods section of the protocol is based on a standard template used by Cochrane Neonatal.

Publisher Copyright:
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

ASJC Scopus Subject Areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD013846

Cite this

@article{dc1d9d6b0fc2450cb6cc9914a9589c57,

title = "Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the comparative effectiveness and safety of prophylactic cyclo-oxygenase inhibitor (COX-I) drugs (indomethacin, ibuprofen, or acetaminophen) and 'no COX-I prophylaxis' in preterm infants, using a Bayesian network meta-analysis.",

author = "Souvik Mitra and Gardner, {Courtney E.} and Abigale MacLellan and Tim Disher and Styranko, {Danielle M.} and Stefan Kuhle and Johnston, {Bradley C.} and Jon Dorling",

note = "Funding Information: We would like to thank Cochrane Neonatal: Colleen Ovelman (Managing Editor), Jane Cracknell (Assistant Managing Editor), Roger Soll (Co-coordinating editor), and Bill McGuire (Co-coordinating Editor), who provided editorial and administrative support. We would also like to thank Robin Parker (WK Kellogg Health Sciences Library, Dalhousie University), as the creator of these searches, and Leah Boulos (Evidence Synthesis Co-ordinator, Maritime SPOR SUPPORT Unit), for her peer review of the MEDLINE search strategy. Menelaos Konstantinidis, Kerry Dwan (Cochrane Methods Support Unit) and Prakeshkumar Shah (Cochrane Neonatal Senior Editor) peer-reviewed and offered feedback for this protocol. The methods section of the protocol is based on a standard template used by Cochrane Neonatal. Publisher Copyright: Copyright {\textcopyright} 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2021",

month = jan,

day = "16",

doi = "10.1002/14651858.CD013846",

language = "English",

volume = "2021",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

TY - JOUR

T1 - Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants

T2 - a network meta-analysis

AU - Mitra, Souvik

AU - Gardner, Courtney E.

AU - MacLellan, Abigale

AU - Disher, Tim

AU - Styranko, Danielle M.

AU - Kuhle, Stefan

AU - Johnston, Bradley C.

AU - Dorling, Jon

N1 - Funding Information: We would like to thank Cochrane Neonatal: Colleen Ovelman (Managing Editor), Jane Cracknell (Assistant Managing Editor), Roger Soll (Co-coordinating editor), and Bill McGuire (Co-coordinating Editor), who provided editorial and administrative support. We would also like to thank Robin Parker (WK Kellogg Health Sciences Library, Dalhousie University), as the creator of these searches, and Leah Boulos (Evidence Synthesis Co-ordinator, Maritime SPOR SUPPORT Unit), for her peer review of the MEDLINE search strategy. Menelaos Konstantinidis, Kerry Dwan (Cochrane Methods Support Unit) and Prakeshkumar Shah (Cochrane Neonatal Senior Editor) peer-reviewed and offered feedback for this protocol. The methods section of the protocol is based on a standard template used by Cochrane Neonatal. Publisher Copyright: Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PY - 2021/1/16

Y1 - 2021/1/16

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the comparative effectiveness and safety of prophylactic cyclo-oxygenase inhibitor (COX-I) drugs (indomethacin, ibuprofen, or acetaminophen) and 'no COX-I prophylaxis' in preterm infants, using a Bayesian network meta-analysis.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the comparative effectiveness and safety of prophylactic cyclo-oxygenase inhibitor (COX-I) drugs (indomethacin, ibuprofen, or acetaminophen) and 'no COX-I prophylaxis' in preterm infants, using a Bayesian network meta-analysis.

UR - http://www.scopus.com/inward/record.url?scp=85103039511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103039511&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD013846

DO - 10.1002/14651858.CD013846

M3 - Article

AN - SCOPUS:85103039511

SN - 1465-1858

VL - 2021

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 1

M1 - CD013846

ER -

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

Abstract

Bibliographical note

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this